PACB,trading below cash,assuming standard 28M quarterly burn rate.
unfamiliar with their genetic testing product,does it have any value going forward?, i see they only recently started marketing their product and have somewhat reduced staffing lately, but based on its recent performance i take it the market is small or their product isn't compelling.
anyone have an opinion on whether this is at least worth a trade based on its cash value or its product?
News 
Market Data 
Discover 
